Intraday MarketsStock report · ALVO · Alvotech · Nov 2, 2026
Intraday Markets
Home › Stocks › ALVO

ALVO Stock: Price, Earnings History and SEC Filings

Alvotech (ALVO) last traded at $4.65, down 4.91% on the latest session and down 19.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.11 against an analyst estimate of $-0.06, a miss of 83.3%.

$4.65 -4.91%
1 month-19.83%
52-week high$6.53
52-week low$2.94
Volume714,818
ExchangeNasdaqGM

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

ALVO earnings history

QuarterReportedEPSEstimateSurprise
Jun 2026Aug 19, 2026$-0.11$-0.06-83.33%
Mar 2026May 6, 2026$-0.09$-0.07-28.57%
Dec 2025Mar 18, 2026$-0.37$0.13-384.62%
Sep 2025Nov 12, 2025$-0.02$0.05-140.00%

ALVO beat the analyst EPS estimate in 0 of its last 4 reported quarters. Source: Nasdaq.

Latest SEC filings for ALVO

Insider filing activity

ALVO insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.

Source: SEC EDGAR.

ALVO news

About Alvotech

Alvotech (ALVO) is a US-listed public company on Nasdaq. The SEC classifies its business as Biological Products (no Diagnostic Substances). It is incorporated in Luxembourg. Its fiscal year ends in December.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed